BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38085566)

  • 1. Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic.
    Elfström M; Gray PG; Dillner J
    Elife; 2023 Dec; 12():. PubMed ID: 38085566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical cancer screening activity in the Capital Region of Denmark before, during and after the COVID-19 pandemic.
    Pedersen BT; Pedersen H; Serizawa R; Sonne SB; Andreasen EK; Bonde J
    Prev Med; 2024 Mar; 180():107888. PubMed ID: 38325609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of self-sampling-based cervical cancer screening strategy using HPV Selfy CE-IVD test coupled with home-collection kit: a clinical study in Italy.
    Feltri G; Valenti G; Isidoro E; Kaur J; Treleani M; Bartelloni A; Mauro C; Spiga F; Ticich G; Di Napoli M; Biagi C; Pachetti M; Centonze S; Castriciano S; Zanchiello S; Giudici F; Gerin D; Zanconati F
    Eur J Med Res; 2023 Dec; 28(1):582. PubMed ID: 38072937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
    Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
    PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Olthof EMG; Aitken CA; Siebers AG; van Kemenade FJ; de Kok IMCM
    Public Health; 2024 Feb; 227():42-48. PubMed ID: 38103276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey.
    Parker S; Deshmukh AA; Chen B; Lairson DR; Daheri M; Vernon SW; Montealegre JR
    Elife; 2023 May; 12():. PubMed ID: 37232493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-sampling in Human Papillomavirus screening during and post-COVID-19 pandemic.
    Tan CS; Hamzah ND; Ismail ZHF; Jerip AR; Kipli M
    Med J Malaysia; 2021 May; 76(3):298-303. PubMed ID: 34031326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Study of the Impact and Restitutive Efforts of Cervical Cancer Screening during the COVID-19 Pandemic in a Regionsl Cancer Centre in Eastern India.
    Bose S; Basu P; Mandal R; Chakrabarti J; Vernekar M; Banerjee D; Chatterjee P; Ray C
    Asian Pac J Cancer Prev; 2023 Oct; 24(10):3495-3500. PubMed ID: 37898855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Operational experiences from the general implementation of HPV self-sampling to Danish screening non-attenders.
    Ejegod DM; Pedersen H; Pedersen BT; Serizawa R; Bonde J
    Prev Med; 2022 Jul; 160():107096. PubMed ID: 35594924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Papillomavirus Self-Sampling for Primary Cervical Cancer Screening in Under-Screened Women in Hong Kong during the COVID-19 Pandemic.
    Ngu SF; Lau LSK; Li J; Wong GCY; Cheung ANY; Ngan HYS; Chan KKL
    Int J Environ Res Public Health; 2022 Feb; 19(5):. PubMed ID: 35270303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptability and Feasibility of HPV Self-Sampling as an Alternative Primary Cervical Cancer Screening in Under-Screened Population Groups: A Cross-Sectional Study.
    Wong EL; Cheung AW; Wong AY; Chan PK
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32867315
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network Across Rural Greece: The GRECOSELF Study.
    Agorastos T; Chatzistamatiou K; Tsertanidou A; Mouchtaropoulou E; Pasentsis K; Kitsou A; Moysiadis T; Moschaki V; Skenderi A; Katsiki E; Aggelidou S; Venizelos I; Ntoula M; Daponte A; Vanakara P; Garas A; Stefos T; Vrekoussis T; Lymberis V; Kontomanolis EN; Makrigiannakis A; Manidakis G; Deligeoroglou E; Panoskaltsis T; Decavalas GO; Michail G; Kalogiannidis I; Koukoulis G; Zempili P; Halatsi D; Truva T; Piha V; Agelena G; Chronopoulou A; Vaitsi V; Chatzaki E; Paschopoulos M; Adonakis G; Kaufmann AM; Hadzidimitriou A; Stamatopoulos K
    Cancer Prev Res (Phila); 2019 Oct; 12(10):701-710. PubMed ID: 31427275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
    Lilliecreutz C; Karlsson H; Spetz Holm AC
    PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
    Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
    BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the self-sampling for cervical cancer screening in Bolivia.
    Allende G; Surriabre P; Cáceres L; Bellot D; Ovando N; Torrico A; Calle P; Ascarrunz C; Alexander S; Bossens M; Fontaine V; Rodríguez P
    BMC Public Health; 2019 Jan; 19(1):80. PubMed ID: 30654774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
    BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The road to cervical cancer elimination in Malaysia: Evaluation of the impact and cost-effectiveness of human papillomavirus screening with self-collection and digital registry support.
    Keane A; Ng CW; Simms KT; Nguyen D; Woo YL; Saville M; Canfell K
    Int J Cancer; 2021 Dec; 149(12):1997-2009. PubMed ID: 34363620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Human Papillomavirus DNA Self-sampling be an Acceptable and Reliable Option for Cervical Cancer Screening in Female Sex Workers?
    Wong ELY; Cheung AWL; Huang F; Chor JSY
    Cancer Nurs; 2018; 41(1):45-52. PubMed ID: 28114260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study.
    Chaw L; Lee SHF; Ja'afar NIH; Lim E; Sharbawi R
    PLoS One; 2022; 17(3):e0262213. PubMed ID: 35287163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vaginal self-sampling on cervical cancer screening rates: a community-based study in Newfoundland.
    Duke P; Godwin M; Ratnam S; Dawson L; Fontaine D; Lear A; Traverso-Yepez M; Graham W; Ravalia M; Mugford G; Pike A; Fortier J; Peach M
    BMC Womens Health; 2015 Jun; 15():47. PubMed ID: 26060041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.